MedTrace Logo

Influence of Acellular Dermal Matrix on Peri-implant Soft Tissue Phenotype and Marginal Bone Loss

NCT07573020 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16

Last updated 2026-05-07

No results posted yet for this study

Summary

To evaluate soft tissue augmentation using acellular dermal matrix (ADM) over immediately placed dental implants in anterior maxilla.

Conditions

  • Immediate Dental Implant Placement
  • Dental Implant
  • Acellular Dermal Matrix
  • Polytetrafluoroethylene
  • Soft Tissue Augmentation at Dental Implants

Interventions

PROCEDURE

Polytetrafluoroethylene coverage

The socket with immediately placed dental implant was covered with a d-PTFE membrane cut to fit the surgical site

PROCEDURE

Acellular Dermal Matrix

The socket with immediately placed dental implant was covered with ADM that was inserted into facial and palatal split thickness pouches.

Sponsors & Collaborators

  • Mansoura University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-04-01
Primary Completion
2025-12-01
Completion
2026-03-01

Countries

  • Egypt

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07573020 on ClinicalTrials.gov